Companies’ intangible capital, such as human, social and environmental capital, are extra-financial factors that give great businesses their competitive edge. Such factors are poorly represented by financial reporting but positively impact a company’s business performance, ultimately leading to positive corporate – and share price – performance.

An example is a Swiss pharmaceutical company, with strong ESG credentials observable in its business model. Its field of oncology is an area of expanding scientific knowledge but it is also one with broad social benefits. By fulfilling patients’ unmet needs, the company can deliver significant improvements to the duration and quality of lives. It has become a trusted partner for medical practitioners, enabling collaboration on new research.

Read the full ‘Sponsored Commentary’ now at the link below